Does fully magnetically centrifugal left ventricular assist device improve overall survival rate in patients with advanced heart failure?
Real-world data from the ELEVATE registry demonstrate a 63.3% overall survival rate at 5 years for primary implants of fully magnetically centrifugal LVADs in advanced heart failure, alongside improved quality of life and functional capacity.
Real-world data from the ELEVATE registry demonstrate an overall survival rate for primary implants of 63.3%. In the PIC, reductions in adverse events for patients in the extended follow-up and improved QoL and functional capacity were observed at 5 years in this patient population with advanced heart failure.
Schmitto et al. (Thu,) studied this question.